June 9, 2023 — Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for ...
June 9, 2023 — Dasi Simulations announced it received FDA clearance for its artificial intelligence model for ...
June 9, 2023 — Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 9, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...
June 9, 2023 — Google Cloud announced a collaboration with Mayo Clinic to transform healthcare with generative AI ...
June 8, 2023 — The Society for Vascular Medicine (SVM) is gearing up with a full program schedule as the June 23 Early ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
June 7, 2023 — GE HealthCare announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based ...
June 7, 2023 — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, announced that the U.S ...
June 7, 2023 — Praveena Paruchuri, MD, is a cardiology specialist with 17 years of experience. She comes to Auburn ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
June 7, 2023 — The U.S. Food and Drug Administration (FDA) has announced the availability of a draft guidance with ...
June 7, 2023 — Magenta Medical Ltd. has announced the initiation of its FDA-approved Early Feasibility Study with the ...
June 6, 2023 — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, have announced that the U ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 6, 2023 — According to a news release issued by the U.S. Food and Drug Administration (FDA), Abiomed has recalled ...
June 5, 2023 — The 2023 Multimodality Appropriate Use Criteria (AUC) for the Detection and Risk Assessment of Chronic ...
June 5, 2023 — Lexicon Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ...
June 09, 2023
